VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update
VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update
Conference call to take place on Friday, November 15 at 8:30 a.m. U.S Eastern Time
將於美國東部時間11月15日星期五上午8:30舉行電話會議
HENDERSON, Nev., Nov. 8, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announces that it will host a conference call on Friday, November 15 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter 2024, in addition to providing a business update. Details of this event can be found below.
內華達州亨德森，2024年11月8日 /美國紐交所: VNRX ("Volition") 今天宣佈，將於美國東部時間11月15日星期五上午8:30舉行電話會議，討論2024年第三季度的財務和運營結果，並提供業務更新。有關此活動的詳細信息如下。
Event: VolitionRx Limited Third Quarter 2024 Earnings and Business Update Conference Call
Date: Friday, November 15, 2024
Time: 8:30 a.m. U.S. Eastern Time
活動: volitionrx 第三季度2024年度收入和業務更新電話會議
日期: 2024年11月15日星期五
時間: 美國東部時間8:30 a.m.
U.S. & Canada Dial-in: 1-877-407-9716 (toll free)
U.K. Dial-in: 0 800 756 3429 (toll free)
Toll/International: 1-201-493-6779
Conference ID: 13750104
美國和加拿大電話：1-877-407-9716（免費）
英國撥入: 0 800 756 3429 (免費電話)
付費電話/國際電話：1-201-493-6779
會議ID: 13750104
Louise Batchelor, Group Chief Marketing & Communications Officer will host the call along with Cameron Reynolds, President and Group Chief Executive Officer of Volition, Terig Hughes, Group Chief Financial Officer, Dr Tom Butera, Chief Executive Officer of Volition Veterinary Diagnostics Development LLC and Dr. Andrew Retter, Chief Medical Officer. The call will provide an update on important events that have taken place in the third quarter of 2024 and upcoming milestones.
Louise Batchelor，集團首席營銷和通信官將與Volition的總裁兼首席執行官卡梅倫·雷諾茲（Cameron Reynolds）、集團首席財務官特里格·休斯（Terig Hughes）、Volition獸醫診斷髮展有限責任公司首席執行官湯姆·布特拉博士（Dr. Tom Butera）和首席醫學官安德魯·雷特博士（Dr. Andrew Retter）共同主持該看漲。通話將更新2024年第三季度發生的重要事件和即將到來的里程碑。
A live audio webcast of the conference call will also be available on this link. In addition, a telephone replay of the call will be available until November 29, 2024. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number 13750104.
會議通話將提供現場音頻網絡廣播，也可通過此鏈接進行。此外，通話的電話回放將在2024年11月29日前提供。回放撥入號碼爲1-844-512-2921（美國和加拿大免費）以及1-412-317-6671（國際收費）。請使用回放PIN碼13750104。
About Volition
關於Volition
Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.
Volition是一家專注於推動表觀遺傳學科學發展的跨國公司。Volition致力於通過更早的檢測、疾病和治療監測，拯救生命並改善患有重大疾病的人和動物的預後。
Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential to not only prolong the life of patients, but also to improve their quality of life.
通過其子公司，Volition正在開發和商業化簡單、易於使用、價格實惠的血液檢測，幫助診斷和監測一系列疾病，包括一些癌症和與NETosis相關的疾病，如敗血症。早期診斷和監測不僅有潛力延長患者的生命，還有助於提高其生活質量。
Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.
Volition的研發活動主要集中在比利時，設有創新實驗室和美國辦公室，並在倫敦和新加坡設有額外辦公室。
The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.
Volition網站地址中的內容不納入本文件的參考範圍，不應視爲本文件的一部分。此類網站地址僅作爲本文件中的非活動文本參考。
Media Enquiries:
媒體查詢:
Louise Batchelor/Debra Daglish,
Volition,
[email protected],
+44 (0)7557 774620
Louise Batchelor/Debra Daglish，
volition，
[email protected]，
+44 (0)7557 774620
SOURCE VolitionRx Limited
來源於VolitionRx有限公司
